PROVIDER PROFILE · NPI 1053772533
Kathleen WeaverARNP
PRESCRIBING · PART D · 2024
Total Rx claims
514
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
17
Brand share
45.7%
Top prescribed drugs
Osimertinib Mesylate114 claims
Oxycodone Hcl58 claims
Alectinib Hcl41 claims
Potassium Chloride41 claims
Apixaban38 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
CROSS-REFERENCE